Top Markets
#1 Black Phoenix Black Phoenix +354.09%
#2 Akedo Akedo +105.75%
#3 Glidr Glidr +84.34%
#4 Gold Park Gold Park +58.04%
#5 Acurast Acurast +39.86%
#6 OpenEden OpenEden +39.66%
#7 BasedHype BasedHype +27.11%
#8 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +22.53%
#9 Cryptopia Cryptopia +21.54%
#10 Avantis Avantis +19.60%
Coin of the day
Black Phoenix Black Phoenix
設定
言語
日本
通貨
USD
テーマ
BiVictriX Therapeutics Plc BiVictriX Therapeutics Plc

BiVictriX Therapeutics Plc

BVX
株式のランク #40612
BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm... BiVictriX Therapeutics Plc is a United Kingdom-based biotechnology firm dedicated to pioneering innovative treatments for cancer. The company's core technology involves its distinctive Bi-Cygni therapeutics, which are engineered to precisely identify and combat specific cancer types. Their foremost development program, BVX001, is currently being advanced to address acute myeloid leukaemia. Established in 2016 as BiVictriX Plc, the organization officially adopted its present name, BiVictriX Therapeutics Plc, in August 2021. Its corporate headquarters are located in Macclesfield, United Kingdom.
株価
$0.13607016
最終同期: 2024-09-10
時価総額
$112.29K
変化（1日）
22.46%
変化（1年）
0.00%
国
GB
取引 BiVictriX Therapeutics Plc (BVX)

カテゴリー

Healthcare
BiVictriX Therapeutics Plc（BVX）のEPS
2026 時点のEPS TTM: 0
BiVictriX Therapeutics Plcの最新の財務報告と株価によると、同社の現在のEPS（TTM）は0です。2026年末には、EPSは0で、2026年のEPS0と同等でした。
BiVictriX Therapeutics PlcのEPS履歴（2026から2026まで）
各年末時点のEPS
年 EPS 変化
提供された日付のデータは十分ではありません。
同様の企業または競合他社のEPS
企業 EPS EPSの差 国
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $17.32 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $27.74 -
NL
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 - -
CH
Samsung Biologics Co.,Ltd. Samsung Biologics Co.,Ltd.
Samsung Biologics Co.,Ltd.
207940.KS
 - -
KR
UCB S.A. UCB S.A.
UCB S.A.
UCB.BR
 $13.70 -
BE